Skip to main content

Table 1 F values and significance levels from two-way ANOVA performed on data obtained by means of HPLC-MS and Western blot in frontal cortex and plasma

From: Acute administration of beta-caryophyllene prevents endocannabinoid system activation during transient common carotid artery occlusion and reperfusion

   

BCCAO/R

BCP treatment

BCP treatment x BCCAO/R

 
 

Marker

F value

p value

F value

p value

F value

p value

DF

Frontal cortex

HPLC-MS

AEA

4.152

0.0482

10.82

0.0021

2.279

ns

1, 40

2-AG

1.804

ns

0.4065

ns

6.427

0.0153

1, 40

PEA

0.4636

ns

12.29

0.0012

19.34

< 0.0001

1, 40

OEA

0.0017

ns

18.19

0.0001

3.7

0.0615

1, 40

DHA

6.972

0.0118

4.826

0.0339

3.205

0.0810

1, 40

Lipoperoxides

5.665

0.0223

12.33

0.0011

4,580

0.0387

1, 39

Western blot

CB1 receptor

16.83

0.0002

14.53

0.0004

0.0136

ns

1, 44

CB2 receptor

15.05

0.0004

0.0396

ns

4.51

0.0401

1, 39

PPAR-alpha

12.29

0.0011

39.66

< 0.0001

6.264

0.0163

1, 42

COX-2

0.1578

ns

0.05464

ns

5.088

0.0299

1, 38

Plasma

HPLC-MS

AEA

11.78

0.0014

44.16

<0.0001

0.824

ns

1, 40

2-AG

7.081

0.0112

1.907

ns

0.0916

ns

1, 40

PEA

1.034

ns

4.605

0.0380

2.119

ns

1, 40

OEA

0.7309

ns

2.321

0.1355

0.4911

ns

1, 40

DHA

1.034

ns

4.605

0.0380

2.119

ns

1, 40

Lipoperoxides

5.879

0.0199

7.68

0.0084

2.547

ns

1, 40